Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05157620 · ClinicalTrials.gov registry record · NA
Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness
A NA study of Schizophrenia and Schizoaffective, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT05157620: Recruiting NA study of Schizophrenia and Schizoaffective, sponsored by VA Office of Research and Development.
NCT05157620 is a NA study of Schizophrenia and Schizoaffective that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 112 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05157620, a NA study of Schizophrenia and Schizoaffective, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a hybrid1, effectiveness-implementation study of yoga-based exercises (YE) as an adjunctive tool for rehabilitation among persons with Severe Mental Illness (SMI). The two-arm randomized controlled trial will compare the efficacy of YE compared to the Wellness Lifestyle Program (WLP). Primary outcomes of the study will be self-report and performance-based measures of community functioning, defined in the investigators study as social, leisure, employment, and life skills functioning in the community. Secondary outcomes will include cognition and physical fitness measures.
Primary Outcome
The Social Functioning Scale (SFS) is a self-report measure of social functioning, and is widely used in adults with psychosis.
Conditions Studied
Interventions
- OTHER Yoga-based Exercise (YE)
- OTHER Wellness Lifestyle Program (WLP)
Study Locations (1)
Pennsylvania
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2022-10-24 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT05157620 shows while recruiting
NCT05157620 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (49% lower).
The record links to 3 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Yoga-based Exercise (YE) is the first listed.
NCT05157620 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05157620 about?
NCT05157620 is a clinical study titled "Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness". This is a hybrid1, effectiveness-implementation study of yoga-based exercises (YE) as an adjunctive tool for rehabilitation among persons with Severe Mental Illness (SMI). The two-arm randomized controlled trial will compare the efficacy of YE compared to the Wellness Lifestyle Program (WLP). Primar...
What is the current status of trial NCT05157620?
This trial is currently recruiting. It is a NA study. The enrollment target is 112 participants. The study started on 2022-10-24. Estimated completion is 2026-05-31.
What conditions does trial NCT05157620 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective, Bipolar Disorder 1.
What interventions are being tested in trial NCT05157620?
The interventions under investigation include: Yoga-based Exercise (YE) (OTHER), Wellness Lifestyle Program (WLP) (OTHER).
Who is sponsoring clinical trial NCT05157620?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05157620 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05157620's enrollment target sits among peer trials
112 129th of 315 higher than 187 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI